Skip to content

SABS

SAB Biotherapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.51
+0.29%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-10.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 18, 2026Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERF-InKind473$0.00
Jun 26, 2026Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERF-InKind988$0.00
Mar 25, 2026Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERF-InKind988$0.00
Feb 5, 2026Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERA-Award2,400,000$4.45
Feb 5, 2026Sullivan Eddie Joe · director, officer: PRESIDENTA-Award3,000,000$4.45
Feb 5, 2026To Lucy · officer: See RemarksA-Award2,400,000$4.45
Feb 5, 2026Reich Samuel J · director, officer: CEOA-Award4,800,000$4.45
Feb 5, 2026Bausch Christoph Lawrence · officer: CHIEF OPERATING OFFICERA-Award1,800,000$4.45
Jan 7, 2026Jain Rita · directorA-Award240,000$3.74
Jan 7, 2026ZACCARDELLI DAVID · directorA-Award240,000$3.74
Dec 18, 2025SKYLER JAY S · directorA-Award150,000$3.99
Dec 18, 2025Lucera Erick · directorA-Award150,000$3.99
Dec 18, 2025Ellias Helen K. · directorA-Award150,000$3.99
Dec 18, 2025Giberson Scott · directorA-Award150,000$3.99
Dec 18, 2025Link David · directorA-Award150,000$3.99
Dec 18, 2025Polvino William James · directorA-Award150,000$3.99
Dec 12, 2025Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERF-InKind988$0.00
Oct 1, 2025Sessa Capital (Master), L.P. · directorM-Exempt17,400$1.75
Oct 1, 2025Sessa Capital (Master), L.P. · directorM-Exempt1,740,000$1.75
Oct 1, 2025Moin Andrew · directorM-Exempt1,740,000$1.75
Oct 1, 2025Moin Andrew · directorM-Exempt17,400$1.75
Sep 22, 2025Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERF-InKind1,977$0.00
Aug 28, 2025Kropotova Alexandra · officer: CHIEF MEDICAL OFFICERA-Award2,400,000$2.17
Aug 28, 2025Bausch Christoph Lawrence · officer: CHIEF OPERATING OFFICERA-Award600,000$2.17
Aug 28, 2025Sullivan Eddie Joe · director, officer: PRESIDENTA-Award3,000,000$2.17
Aug 28, 2025Reich Samuel J · director, officer: CEO & EXECUTIVE CHAIRMANA-Award4,800,000$2.17
Aug 28, 2025To Lucy · officer: See RemarksA-Award1,200,000$2.17
Jul 24, 2025Moin Andrew · directorA-Award228,500$1.75
Jul 24, 2025Sessa Capital (Master), L.P. · directorA-Award228,500$1.75
Jul 24, 2025Sessa Capital (Master), L.P. · directorA-Award114,250$219
Institutional positioning

13F filings over the trailing two quarters

New 65Increased 54Reduced 23Sold out 21
FilerActionSharesFiled
VIVO CAPITAL, LLCUnchanged11,420,000May 20, 2026
CALIGAN PARTNERS LPNew Position7,967,207May 15, 2026
Caligan Partners LPUnchanged7,967,207Aug 14, 2026
Vivo Capital, LLCReduced7,299,909Aug 14, 2026
PERCEPTIVE ADVISORS LLCIncreased6,627,501Aug 14, 2026
PERCEPTIVE ADVISORS LLCIncreased6,431,743May 29, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased6,405,553Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged4,401,500Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged4,401,500May 15, 2026
COMMODORE CAPITAL LPUnchanged4,401,500May 15, 2026
BALYASNY ASSET MANAGEMENT L.P.Unchanged3,760,439Aug 14, 2026
BALYASNY ASSET MANAGEMENT L.P.Increased3,760,439May 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.New Position3,405,553May 15, 2026
BlackRock, Inc.Increased3,066,016Aug 7, 2026
MILLENNIUM MANAGEMENT LLCIncreased3,032,697May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 18, 2026